How has been the historical performance of Fischer Medical?

Answer:The historical performance of Fischer Medical shows significant growth in various financial metrics from March 2024 to March 2025.

Breakdown:
Fischer Medical's net sales surged to 110.70 Cr in March 2025 from 20.98 Cr in March 2024, indicating a substantial increase in total operating income, which also rose to 110.70 Cr from 20.98 Cr. The company's total expenditure, excluding depreciation, increased to 107.38 Cr from 19.12 Cr, driven primarily by a rise in the purchase of finished goods, which jumped to 95.28 Cr from just 0.08 Cr. Operating profit (PBDIT) improved to 4.81 Cr from 2.36 Cr, while profit before tax increased to 2.71 Cr from 2.11 Cr. However, profit after tax slightly declined to 1.70 Cr from 1.84 Cr, leading to a decrease in earnings per share (EPS) from 0.34 to 0.27. On the balance sheet, total assets grew significantly to 456.98 Cr from 86.32 Cr, with total liabilities also rising to 456.98 Cr from 86.32 Cr. Cash flow from financing activities saw a notable increase to 314.00 Cr from 37.00 Cr, contributing to a net cash inflow of 103.00 Cr compared to no inflow in the previous year. Overall, Fischer Medical's financial performance reflects a period of rapid growth and expansion, despite some challenges in profitability metrics.